MYIA
Mount Yale Investment Advisors Portfolio holdings
AUM
$1.28B
1-Year Return
17.56%
This Quarter Return
+7.46%
1 Year Return
+17.56%
3 Year Return
+73.55%
5 Year Return
+134.29%
10 Year Return
–
AUM
$573M
AUM Growth
+$44.7M
(+8.5%)
Cap. Flow
+$35M
Cap. Flow
% of AUM
6.12%
Top 10 Holdings %
Top 10 Hldgs %
26.32%
Holding
1,039
New
98
Increased
283
Reduced
430
Closed
91
Top Buys
| 1 |
Apple
AAPL
|
+$31.5M |
| 2 |
Cummins
CMI
|
+$7.67M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$7.38M |
| 4 |
Lam Research
LRCX
|
+$7.33M |
| 5 |
Citigroup
C
|
+$7.08M |
Top Sells
| 1 |
Eli Lilly
LLY
|
+$9.1M |
| 2 |
W.W. Grainger
GWW
|
+$7.29M |
| 3 |
IBM
IBM
|
+$6.25M |
| 4 |
AbbVie
ABBV
|
+$5.76M |
| 5 |
FNBG
FNB Bancorp Common Stock
FNBG
|
+$4.63M |
Sector Composition
| 1 | Technology | 23.97% |
| 2 | Financials | 13.24% |
| 3 | Healthcare | 11.9% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 7.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Allstate
ALL
$52.8B
| $260K | 0.05% |
2,815
-8
| -0.3% | -$739 |
|
|
PTR
277
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $256K | 0.04% |
+3,338
| New | +$256K |
|
278
Salesforce
CRM
$240B
| $254K | 0.04% |
1,794
-8
| -0.4% | -$1.13K |
|
|
NAGE
279
Niagen Bioscience, Inc. Common Stock
NAGE
$754M
| $254K | 0.04% |
68,541
| – | – |
|
280
American Express
AXP
$226B
| $250K | 0.04% |
2,331
-566
| -20% | -$60.7K |
|
281
Eaton
ETN
$136B
| $249K | 0.04% |
3,301
-1
| -0% | -$75 |
|
282
Vanguard Dividend Appreciation ETF
VIG
$96.2B
| $248K | 0.04% |
2,289
-2,532
| -53% | -$274K |
|
283
Adobe
ADBE
$152B
| $246K | 0.04% |
970
+286
| +42% | +$72.5K |
|
284
Sysco
SYY
$39B
| $245K | 0.04% |
3,681
-122
| -3% | -$8.12K |
|
285
Marriott Vacations Worldwide
VAC
$2.71B
| $245K | 0.04% |
2,676
+504
| +23% | +$46.1K |
|
286
BP
BP
$87.3B
| $244K | 0.04% |
5,931
+166
| +3% | +$6.83K |
|
287
Criteo
CRTO
$1.24B
| $243K | 0.04% |
11,364
+572
| +5% | +$12.2K |
|
288
Boyd Gaming
BYD
$6.92B
| $241K | 0.04% |
8,835
+7,892
| +837% | +$215K |
|
289
Emergent Biosolutions
EBS
$403M
| $240K | 0.04% |
3,453
-947
| -22% | -$65.8K |
|
290
MasTec
MTZ
$13.9B
| $239K | 0.04% |
4,874
+1,870
| +62% | +$91.7K |
|
|
291
IBM
IBM
$239B
| $232K | 0.04% |
1,946
-52,450
| -96% | -$6.25M |
|
292
iShares 7-10 Year Treasury Bond ETF
IEF
$36B
| $227K | 0.04% |
2,268
| – | – |
|
293
DXC Technology
DXC
$2.62B
| $221K | 0.04% |
3,490
+461
| +15% | +$29.2K |
|
294
Upland Software
UPLD
$67.6M
| $219K | 0.04% |
6,717
-9
| -0.1% | -$293 |
|
295
Chesapeake Utilities
CPK
$2.9B
| $215K | 0.04% |
2,630
-126
| -5% | -$10.3K |
|
296
Patrick Industries
PATK
$3.77B
| $214K | 0.04% |
6,840
+768
| +13% | +$24K |
|
|
BEAT
297
DELISTED
BioTelemetry, Inc.
BEAT
| $212K | 0.04% |
3,134
-618
| -16% | -$41.8K |
|
298
Brinker International
EAT
$6.97B
| $210K | 0.04% |
4,281
| – | – |
|
299
AES
AES
$9.06B
| $209K | 0.04% |
13,411
-22
| -0.2% | -$343 |
|
300
PIMCO Corporate & Income Opportunity Fund
PTY
$2.68B
| $208K | 0.04% |
12,000
| – | – |
|